Immix Biopharma | Investor Presentation Deck | 64 slides · page 12 of 64
The slide uses a combination of bar charts for preclinical data and a summary table for clinical outcomes to demonstrate the superiority of NXC-201.
Deck · comparison_table · compare_peers · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 chart 1/1 source-note 1/1 table 1/1 title 1/1
Components 5
primary bar-grouped source-note data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1